Welcome to our dedicated page for DLH Holdings news (Ticker: DLHC), a resource for investors and traders seeking the latest updates and insights on DLH Holdings stock.
DLH Holdings Corp. (NASDAQ: DLHC) is a leading provider of technology-enabled business process outsourcing and program management solutions in the United States. The company leverages digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems to support large-scale federal health and human services initiatives. DLH's mission is to be the most trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services to those securing the freedom of our nation, veterans, and underserved communities.
DLH delivers professional healthcare and public services to several government agencies, including the U.S. Departments of Defense, Health and Human Services, and Veterans Affairs. The company is engaged in key areas such as defense and veterans health solutions, human services and solutions, and public health and life sciences. With more than 3,200 employees working across 30 states, DLH brings a unique combination of government sector experience and commitment to innovation.
DLH has been recognized by GovWin IQ as a top service provider in the health services spending category. Recently, the company has seen significant growth and further debt reduction, positioning it well for future endeavors. The company continually strives to enhance technology, public health, and cybersecurity readiness through science, technology, cyber, and engineering solutions and services.
One notable achievement is DLH's new award with the National Institute on Drug Abuse (NIDA), valued at approximately $23 million. This contract includes managing the operations of an integrated advanced clinical/research informatics system, supporting the research, design, development, and maintenance of clinical and scientific informatics, and providing IT infrastructure and desktop support. This partnership underscores DLH’s commitment to delivering superb execution and excellence in public health services.
Financially, DLH has reported a positive trajectory with increased income from operations, higher net income, and a robust backlog of projects. For the first quarter of fiscal 2024, the company recorded income from operations of $6.8 million, and net income of approximately $2.2 million, showing significant improvement compared to the previous year. As of the latest updates, the total backlog stands at approximately $736.2 million, signaling strong future performance and continued growth.
DLH Holdings Corp. (NASDAQ: DLHC) reported third-quarter fiscal 2021 revenue of $61.6 million, up from $51.5 million in the previous year, primarily attributed to the acquisition of Irving Burton Associates and organic growth. Operating margins improved to 8.0% from 7.4%. Net income rose to $2.9 million or $0.21 per diluted share, reflecting strong demand for technology-enabled solutions. Year-to-date operating cash flow reached $15.4 million. The backlog totaled $566.2 million, indicating robust future prospects.
DLH Holdings Corp. (NASDAQ: DLHC) will announce its financial results for the fiscal third quarter on August 4, 2021, after market close. A conference call for investors is scheduled for August 5, 2021, at 10:00 a.m. ET, featuring senior management's presentation on the financial results and operating trends, followed by a Q&A session. Interested participants can listen in by dialing specific numbers or accessing the replay on the company’s website. DLH provides various health services to federal agencies and boasts over 2,200 employees.
DLH Holdings Corp. (NASDAQ: DLHC) reported a revenue increase to $61.5 million for Q2 FY2021, up from $54.8 million in Q2 FY2020, largely due to the acquisition of IBA. Operating margins expanded to 7.5%, with earnings of $2.6 million ($0.19 per share), compared to $2.1 million ($0.16 per share) the previous year. A significant contract award from the VA for $202 million further enhances revenue visibility. The company’s backlog stood at $608.7 million as of March 31, 2021, excluding the new contract.
DLH Holdings Corp. (NASDAQ: DLHC) announced a follow-on contract with the Department of Veterans Affairs worth $202 million to provide medical logistics for the Consolidated Mail Outpatient Pharmacy. This contract spans one year with four optional extensions. It highlights DLH's strong 20-year partnership with the VA and the importance of mail order in veteran care, especially during the COVID-19 pandemic. Last year, the CMOP program processed over 120 million prescriptions nationwide, showcasing DLH's role in improving pharmaceutical delivery to veterans.
DLH Holdings Corp. (NASDAQ: DLHC) will announce its financial results for the fiscal second quarter ending March 31, 2021, on May 5, 2021, after market close. A conference call for investors will be held on May 6, 2021, at 11:00 a.m. ET, where management will discuss the results and operational performance. Interested parties can access the call via phone or through the Investor Relations section of the DLH website, where presentation materials will also be available. DLH specializes in healthcare and human services for federal agencies, employing over 2,200 staff.
DLH Holdings Corp. (NASDAQ: DLHC) will release its fiscal first quarter financial results for the period ending December 31, 2020, on February 2, 2021, after market close. A conference call for investors is scheduled for February 3, 2021, at 11:00 a.m. Eastern Time, featuring senior management discussing financial results and operating trends, followed by a Q&A session. Interested parties can participate by calling 888-347-5290 or 412-317-5256. For more information about DLH’s services and operations, visit www.dlhcorp.com.
DLH Holdings Corp. (NASDAQ: DLHC) has secured a contract valued at up to $42 million to continue operating the AIDS Clinical Trials Group's (ACTG) Network Coordinating Center (NCC), funded by the National Institutes of Health. This contract spans one base year and six option years. DLH, managing the NCC since 1987, provides essential support for HIV research and clinical trials, bolstering public health initiatives. The ACTG network, active in 15 countries, is pivotal in HIV treatment improvements and has recently expanded its research to include studies for COVID-19.
DLH Holdings Corp. (NASDAQ: DLHC) announced its participation in two virtual investor events in Q1 2021. The company will attend the Noble Capital Markets’ 17th Annual Small & Microcap Investor Conference on January 20, and the Alliance Global Partners’ Emerging Growth Technology Conference on February 4. DLH is a leading provider of healthcare services to federal agencies, focusing on technology-enabled health services for military and veterans. Additional details, including presentation materials and opportunities for one-on-one meetings, will be available on the company’s website.
DLH Holdings Corp. (NASDAQ: DLHC) reported fiscal 2020 annual revenue of $209.2 million, up from $160.4 million in 2019, driven by new awards and acquisitions despite COVID-19 impacts. Earnings increased to $0.54 per diluted share from $0.41. Cash flow from operations reached $19.5 million, with a significant debt reduction of $19 million. The acquisition of Irving Burton Associates (IBA) for $32 million added over $140 million to the company’s backlog of $688.4 million.
FAQ
What is the current stock price of DLH Holdings (DLHC)?
What is the market cap of DLH Holdings (DLHC)?
What services does DLH Holdings Corp. provide?
Which government agencies does DLH serve?
How many employees does DLH have?
What are the key areas of DLH's services?
Has DLH received any recent recognitions?
What are some of DLH's recent financial achievements?
What recent contract has DLH secured with NIDA?
What technologies does DLH leverage in its operations?
What is DLH's mission?
Where can I find more information about DLH?
